Effects of phosphodiesterase inhibitors on cytokine production by microglia

Abstract

Type III and IV phosphodiesterase inhibitors (PDEIs) have recently been shown to suppress the production of TNF-α in several types of cells. In the present study, we have shown that all the types of PDEIs, from type 1- to V-specific and non-specific, suppress the production of TNF-α by mouse microglia stimulated with lipopolysaccharide (LPS) in a dose-dependent manner. Certain combinations of three different types of PDEIs synergistically suppressed TNF-α production by microglia at a very low concentration (1 μM). Since some PDEIs reportedly pass through the blood-brain barrier (BBB), the combination of three PDEIs may be worth trying in neurological diseases, such as multiple sclerosis and HIV-related neurological diseases in which TNF-α may play a critical role. Some PDEIs also suppressed interleukin-1 (IL-1) and IL-6 production by mouse microglia stimulated with LPS. In contrast, the production of IL-10, which is known to be an inhibitory cytokine, was upregulated by certain PDEIs. The suppression of TNF-α and induction of IL-10 were confirmed at the mRNA level by RT - PCR. PDEIs may be useful anti-inflammatory agents by downregulating inflammatory cytokines and upregulating inhibitory cytokines in the central nervous system. (CNS).

Keywords

multiple sclerosis TNFa phosphodiesterase inhibitor microglia

Get full access to this article

View all access options for this article.

References

Selmaj KW , Raine CS. (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro . Ann Neurol 23: 339-346 .

Hartung HP et al. (1995) Circulating adhesion molecules and inflammatory mediators in demyelination . Neurology 45 (supp 6) S22-s38 .

Inoue A et al. (1996) The level of tumor necrosis factor-α producing cells in the spinal cord correlates with the degree of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Int . Immunology 8: 1001-1008 .

Sharief MK , Phil M , Hentges R. (1991) Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis . N Engl JMed 325: 467-472 .

Selmaj K , Raine CS , Cross AH. (1991) Anti-tumor necrosis factor therapy abrogates autoimmune demyeli-nation . Ann Neurol 30: 694-700 .

Ruddle NH et al. (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis . J Exp Med 172: 1193-1200 .

Probert L et al. (1995) Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor a . Proc Natl Acad Sci USA 92: 11294-11298 .

Renz H et al. (1988) Release of tumor necrosis factor-α from macrophages . J Immunol 141: 2388-2393 .

Strieter RM et al. (1988) Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline . Biochem Biophys Res Commun 155: 1230-1236 .

10.

Asano T , Ochiai Y , Hidaka H. (1977) Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors . Mol Pharmacol 13: 400-406 .

11.

Hidaka H et al. (1979) Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation . J Pharmacol Exp Ther 211: 26-30 .

12.

Nataf S et al. (1993) Pentoxifylline inhibits experimental allergic encephalomyelitis . Acta Neurol Scand 88: 97-99 .

13.

Sommer N et al. (1995) The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis . Nature Medicine 1: 244-248 .

14.

Genain CP et al. (1995) Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor . Proc Natl Acad Sci USA 92: 3601-3605 .

15.

Knudsen PJ , Dinarello CA , Strom TB. (1986) Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate . J Immunol 137: 3189-3194 .

16.

Brandwein SR. (1986) Regulation of interleukin 1 production by mouse peritoneal macrophages . JBiol Chem 261: 8624-8632 .

17.

Scordamaglia A , Ciprandi G , Ruffoni S , Caria M. (1988) Theophylline and the immune response; in vitro and in vivo effects . Clin Immunol Immunopathol 48: 238-246 .

18.

Riekman P et al. (1996) Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis . J Neuroimmunol 64: 193-200 .

19.

Mizuno T , Sawada M , Marunouchi T , Suzumura A. (1994) Production of interleukin-10 by mouse glial cells in culture . Biochem Biophys Res Commun 205: 1907-1915 .

20.

Howard J et al. (1992) Biological properties of interleukin 10 . J Clin Immunol 12: 239-247 .

21.

Suzumura A , Eccleston PA , Bhat S , Silberberg DH. (1984) The isolation and long-term culture of oligodendrocytes from newborn mouse brain . Brain Res 324: 379-383 .

22.

Suzumura A , Mezitis SGE , Gonatus N , Silberberg DH. (1987) MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain; induction of Ia antigen expression by gamma-interferon . JNeuroimmunol 15: 263-278 .

23.

Chomczynski P , Sacchi N. (1987) Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction . Ann Biochem 162: 156-159 .

24.

Sawada M , Suzumura A , Marunouchi T. (1992) TNF alpha induces IL-6 production by astrocytes but not by microglia . Brain Res 583: 296-299 .

25.

Sawada M , Kondo N , Suzumura A , Marunouchi T. (1989) Production of tumor necrosis factor alpha by microglia and astrocytes in culture . Brain Res 491: 394-397 .

26.

Hopkins SJ , Humphery M. (1989) Simple, sensitive and specific bioassay of interleukin-1 . J Immunol Meth 120: 271-276 .

27.

Matsuda T , Hirano T , Kishimoto T. (1988) Establishment of interleukin 6(IL-6)/B cell stimulatory factor 2 (BSF-2)-dependent cell line and preparation of anti-IL-6/BSF-2 monoclonal antibodies . Eur J Immunol 18: 951-956 .

28.

Endres S et al. (1991) Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-α and interleukin-1β by human mononuclear cells . Immunology 72: 56-60 .

29.

Sonnenburg WK , Seger D , Beavo JA. (1993) Molecular cloning of a cDNA encoding the “61-kDa” calmodulin-stimulated cyclic nucleotide phosphodiesterase . JBiol Chem 268: 645-652 .

30.

McAllister-Lucas LM , Sonnenburg WK , Kadlecek A , Seger D. (1993) The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase deduced from a cDNA clone. J . Biol Chem 268: 22863-22873 .

31.

Lee SC et al. (1993) Cytokine production by human fetal microglia and astrocytes . J Immunol 150: 2659-2667 .

32.

Lee SC , Dickson DW , Loi W , Brosnan CF. (1993) Induction of nitric oxide synthase activity in human astrocytes by interleukin-1β and interferon-g . JNeuro immunol 46: 19-24 .

33.

Johns LD , Flanders KC , Rangers GE , Striam S. (1991) Successful treatment of experimental allergic encephalomyelitis with transforming growth factor beta 1 . J Immunol 147: 1792-1796 .